Description
Recombinant monoclonal antibody to CA125. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 20E3.
Target
CA125
Target Alias Names
TA347, Mucin-16, MUC-16, Ovarian cancer-related tumor marker CA125, CA-125, Ovarian carcinoma antigen CA125, CGMCC NO 20773
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression